Zynex Stock Forecast for 2023 - 2025 - 2030
Updated on 04/26/2024
Zynex Stock Forecast and Price Target
Given the average yearlong price target of $16.50 provided by prominent analysts over the past few months, there is a potential upside of approximately 50.82% from the last closing price in April, 2024 for Zynex's stock if it is reached. This estimation is based on a high estimate of $27.00 and a low estimate of $15.00. You may be interested in rivals even if you aren't interested in Zynex stock.
50.82% Upside
Zynex Fair Value Forecast for 2023 - 2025 - 2030
Zynex's Price has decreased by 100.00% In the last four years, from $5.02 to $0.00. For the next year, analysts are expecting Fair Value to reach $11.30 – an increase of 100.00%. Over the next seven years, experts predict that Fair Value will grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ABT Stock Forecast | Abbott Laboratories | Outperform |
9
|
$106.86 | Buy/Sell | $118.92 | 18.38% |
| ISRG Stock Forecast | Intuitive Surgical | Outperform |
13
|
$373.12 | Buy/Sell | $408.45 | 15.24% |
| BSX Stock Forecast | Boston Scientific | Outperform |
11
|
$73.26 | Buy/Sell | $70.14 | 9.20% |
| MDT Stock Forecast | Medtronic | Outperform |
11
|
$79.25 | Buy/Sell | $92.47 | 20.50% |
| DXCM Stock Forecast | DexCom Inc | Buy |
12
|
$138.01 | Buy/Sell | $125.98 | 8.69% |
Zynex Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Zynex's Revenue has grown by 130.05%, from $80.12M to $184.32M. For the next year, analysts are expecting Revenue to reach $232.85M – an increase of 26.33%. Over the next seven years, experts predict that Revenue will grow by 121.78%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| RMD Stock Forecast | ResMed Inc | Outperform |
17
|
$183.42 | Buy/Sell | $201.32 | 11.77% |
| VAR Stock Forecast | Varian Medical Systems | - |
16
|
$176.53 | Buy/Sell | $177.67 | -100.00% |
| SWAV Stock Forecast | Shockwave Medical | Hold |
4
|
$328.99 | Buy/Sell | $239.91 | 1.83% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PODD Stock Forecast | Insulet | Outperform |
15
|
$164.17 | Buy/Sell | $222.05 | 43.75% |
| LVGO Stock Forecast | Livongo Health | - |
0
|
$0.00 | Buy/Sell | $126.17 | 0.00% |
| MASI Stock Forecast | Masimo | Outperform |
14
|
$135.24 | Buy/Sell | $96.33 | 16.90% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| INSP Stock Forecast | Inspire Medical Systems | Outperform |
6
|
$231.01 | Buy/Sell | $225.45 | 14.71% |
| ITGR Stock Forecast | Integer Holdings | Outperform |
16
|
$111.15 | Buy/Sell | $95.00 | 16.96% |
| AXNX Stock Forecast | Axonics | Hold |
7
|
$66.54 | Buy/Sell | $70.15 | 6.70% |
Zynex EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Zynex's EBITDA has grown by 26.90%, rising from $11.82M to $15.00M. For next year, analysts predict EBITDA of $32.58M, which would mean an increase of 117.20%. Over the next seven years, experts predict that Zynex's EBITDA will grow at a rate of 472.07%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CMD Stock Forecast | Cantel Medical LLC | - |
17
|
$0.05 | Buy/Sell | $85.00 | -100.00% |
| IRTC Stock Forecast | iRhythm Technologies | Buy |
11
|
$111.27 | Buy/Sell | $126.70 | 21.33% |
| TMDX Stock Forecast | TransMedics Group | Outperform |
8
|
$89.25 | Buy/Sell | $90.00 | 13.17% |
Zynex EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Zynex's EBIT has grown, rising from $10.25M to $10.78M – a growth of 5.17%. In the next year, analysts believe that EBIT will reach $27.79M – an increase of 157.79%. For the next seven years, the forecast is for EBIT to grow by 680.62%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| TNDM Stock Forecast | Tandem Diabetes Care | Outperform |
9
|
$35.56 | Buy/Sell | $30.80 | 2.64% |
| CNMD Stock Forecast | CONMED | Outperform |
16
|
$61.90 | Buy/Sell | $123.38 | 39.74% |
| GNMK Stock Forecast | GenMark Diagnostics | - |
2
|
$0.00 | Buy/Sell | $24.05 | 0.00% |
Zynex EPS Price Prediction Forecast for 2023 - 2025 - 2030
Zynex's EPS has decreased by 100.00% In the last four years, from $0.24 to $0.00. For the next year, analysts are expecting EPS to reach $0.54 – an increase of 100.00%. Over the next seven years, experts predict that EPS will grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| NTUS Stock Forecast | Natus Medical | - |
14
|
$32.96 | Buy/Sell | $36.00 | 16.60% |
| QTRX Stock Forecast | Quanterix | Outperform |
11
|
$15.59 | Buy/Sell | $32.00 | 105.26% |
| SILK Stock Forecast | Silk Road Medical, Inc | Outperform |
7
|
$17.65 | Buy/Sell | $12.33 | 7.65% |
.jpg)